News Agencies Feed 

TECHNOLOGY

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017
December 11, 2017

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research strategy – investigating both cancer cell-directed therapies and immune cell-directed therapies. This multi-faceted approach offers the potential to bring innovative opportunities"...

Continue Reading >

4KUNIVERSE to Launch in Swiss TV Households via SES
December 11, 2017

4KUNIVERSE makes its international debut beyond North America this week, as SES begins distribution of the fast-growing Ultra HD channel to Swisscom, Switzerland’s leading telecom company and one of its top IT firms, with 1.45 million television customers across Switzerland.

Swisscom is adding 4KUNIVERSE to its expanding Ultra HD offering, which already includes a growing channel"...

Continue Reading >

AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
December 11, 2017

AstraZeneca and Acerta Pharma, its haematology research and development centre of excellence, today presented results from the Phase Ib/II ACE-CL-003 clinical trial (Abstract #432) and updated results from the Phase I/II ACE-CL-001 (Abstract #498) clinical trial that are testing Calquence (acalabrutinib) alone and in combination for the treatment of chronic lymphocytic leukaemia (CLL) in multiple treatment settings. The findings were presented during two oral sessions"...

Continue Reading >

Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
December 10, 2017

Celgene Corporation (NASDAQ: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-B-cell maturation antigen (BCMA) CAR T cell therapy, in 21 patients with late-stage relapsed/refractory multiple myeloma will be presented in an oral presentation at the American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia. The objective of this Phase 1 dose-escalation study is to evaluate safety and efficacy of bb2121 and determine a recommended Phase 2 dose. “Celgene has a longstanding commitment to patients with multiple myeloma through our extensive research efforts in this deadly blood cancer,” said Nadim Ahmed, President, Hematology and Oncology for Celgene. “Looking ahead,......

Continue Reading >

Emirates Hospital Advances Breast Cancer Care with New Sentimag® Technology
December 10, 2017

Emirates Hospital, a subsidiary of Emirates Healthcare and located in Dubai, has become the first healthcare facility in the UAE to acquire Sentimag®, an innovative medical device that greatly improves a clinician’s ability to precisely diagnose breast cancer. It also helps the clinician to make an informed decision regarding a patient’s post-operative care. As surgeons want to remove as little tissue as possible during surgery, Sentimag® will"...

Continue Reading >

Toshiba Electronic Devices & Storage Corporation Launches World's First 14TB HDD with Conventional Magnetic Recording
December 9, 2017

Toshiba Electronic Devices & Storage Corporation today announced the launch of the MG07ACA Series, the world’s first[1] enterprise 14TB[2] Conventional Magnetic Recording (CMR) HDD. Using a 9-disk, helium-sealed design, the new MG07ACA Series provides the power-efficient capacity and storage density needed by cloud-scale and enterprise storage solution providers to achieve their TCO objectives. “We have raised the bar with the new MG07ACA Series 9-disk helium-sealed design,” said Akitoshi Iwata, Vice President of Storage Products Division, Toshiba Electronic Devices and Storage Corporation. “By utilizing an innovative design, we continue to improve the benefits that high-capacity disk storage can deliver to our broad global customer base.” The MG07ACA Series features both 14TB 9-disk and 12TB 8-disk models. The helium-sealed 3.5-inch[3] mechanical design realizes better storage density and a lower HDD operating power profile......

Continue Reading >

Bertin and Zymo Research Announce New Collaboration
December 8, 2017

Zymo Research Corp. and Bertin announce a collaboration that ensures the sample lysis step in the microbiome workflow is complete and unbiased. An application note is available describing the materials, procedure and results attained using the Precellys®Evolution Homogenizer together with the ZymoBIOMICS® Microbial Community Standards and ZymoBIOMICS DNA Miniprep Kit for purification of the DNA. Using both companies’ products, the researcher is afforded unbiased cell lysis in only one minute. The application note validates a procedure for accurate downstream microbiome measurements. Zymo Research’s suite of ZymoBIOMICS® products addresses the complete Microbiomics workflow; from sample collection, DNA extraction, library prep, sequencing, through bioinformatics and final analysis. The ZymoBIOMICS®Microbial Community Standard contains three easy-to-lyse Gram-negative bacteria, five tough-to-lyse Gram-positive bacteria, and two tough-to-lyse......

Continue Reading >

Idemia and FlexiGroup To Launch Australia’s First MOTION CODETM Credit Card
December 8, 2017

IDEMIA, the global leader in trusted identities for an increasingly digital world, today announces its partnership with FlexiGroup, Australia’s market leader in Point of Sale consumer and commercial finance to launch Australia’s first MOTION CODETM credit card.

Developed by IDEMIA (formerly known as OT-Morpho), the MOTION CODETM credit card1 is a high-tech payment card with"...

Continue Reading >

Neustar Launches Next Generation DDoS Defense Network: SiteProtect NG™
December 8, 2017

Neustar, Inc., a trusted, neutral provider of real-time information services, today launched SiteProtect NG™ (Next Generation), its new solution to protect brands against DDoS (distributed denial of service) attacks. It is the latest wave of the company’s purpose-built DDoS mitigation solution designed to meet the security requirements of all brands, on-premise and in the cloud, to deal with the next generation of cyber threats. This powerful upgrade adds Neustar’s state of the art WAF (web application firewall) solution to the award-winning Neustar SiteProtect solution to extend network protection to the application layer. A new real-time user interface provides consolidated in-depth trend analysis and gives brands unprecedented access to attack forensics that are not currently available through traditional defense services. “Years of experience and cybersecurity engineering capabilities have gone into the development of the SiteProtect......

Continue Reading >

Ficosa Awards IDEMIA as Best Supplier of the Year
December 7, 2017

(AETOS Wire)-- IDEMIA, the world leader in trusted identities for an increasingly digital world, announced today that it has received the “Best Supplier for Electronics 2016 Award” by Ficosa, a top-tier provider of systems and components for the automotive and mobility sector.

IDEMIA has been providing Device Identity Modules® (DIM),"...

Continue Reading >